Disposable Medical Biosensor Monitors Patients Remotely
|
By HospiMedica International staff writers Posted on 28 Jul 2020 |

Image: The LifeSignals LP1250 Remote Monitoring Patch Platform (Photo courtesy of LifeSignals)
A single-use two channel electrocardiogram (ECG) and heart rate biosensor provides up to three days of patient monitoring with remote data access.
The LifeSignals (Fremont, CA, USA) LP1250 Remote Monitoring Patch Platform is a wireless system designed for the continuous collection and monitoring of cardiac data in ambulatory, hospital, home, and healthcare settings. The data is transmitted wirelessly from the LP1250 to a remote secure server for storage and analysis. The monitoring patch can be integrated into clinical workflows, including remote patient monitoring systems, mobile cardiac telemetry systems, and Holter and event monitoring systems.
Features include a proprietary single-chip (LC1100) processor platform that allows secure capture, storage, and transmission of patient data, even in multi-patient hospital environments that produce multiple interferences; up to 72-hour data capture of both two-channel ECG and heart rate data; and a lightweight and splash-proof profile that improve patient comfort and compliance. The LP1250 will be sold worldwide by LifeSignals as a white-labeled device through a network of partnerships from OEMs and telehealth software providers to specialist hospital facilities.
“Healthcare professionals can remotely access patient data via third-party software for the screening and monitoring of common cardiac arrhythmias such atrial fibrillation, enabling rapid treatment decisions, independent of patient location,” said Surendar Magar, co-founder and CEO of LifeSignals. “The interoperable biosensor gives partners access to a ready-to-integrate, multi-parameter medical wearable with a straightforward ecosystem for fast on-boarding.”
Related Links:
LifeSignals
The LifeSignals (Fremont, CA, USA) LP1250 Remote Monitoring Patch Platform is a wireless system designed for the continuous collection and monitoring of cardiac data in ambulatory, hospital, home, and healthcare settings. The data is transmitted wirelessly from the LP1250 to a remote secure server for storage and analysis. The monitoring patch can be integrated into clinical workflows, including remote patient monitoring systems, mobile cardiac telemetry systems, and Holter and event monitoring systems.
Features include a proprietary single-chip (LC1100) processor platform that allows secure capture, storage, and transmission of patient data, even in multi-patient hospital environments that produce multiple interferences; up to 72-hour data capture of both two-channel ECG and heart rate data; and a lightweight and splash-proof profile that improve patient comfort and compliance. The LP1250 will be sold worldwide by LifeSignals as a white-labeled device through a network of partnerships from OEMs and telehealth software providers to specialist hospital facilities.
“Healthcare professionals can remotely access patient data via third-party software for the screening and monitoring of common cardiac arrhythmias such atrial fibrillation, enabling rapid treatment decisions, independent of patient location,” said Surendar Magar, co-founder and CEO of LifeSignals. “The interoperable biosensor gives partners access to a ready-to-integrate, multi-parameter medical wearable with a straightforward ecosystem for fast on-boarding.”
Related Links:
LifeSignals
Latest Critical Care News
- Magnetic Control System Enables Precise Navigation of Miniature Medical Devices
- Noninvasive Skull Sensor Detects Early Deterioration in Acute Brain Injury
- Automated Robotic Imaging System Enhances Full-Body Skin Cancer Screening
- Bacteria-Resistant Urinary Catheter Coating Reduces Infections and Antibiotic Use
- Sensor-Integrated Airway Stent Enables Continuous Remote Monitoring
- Graphene-Based Material Selectively Eliminates Bacteria While Sparing Human Cells
- Flexible Plastic Film Uses Nanostructures to Destroy Viruses
- Finger Cuff Algorithm Enables Noninvasive Screening for Aortic Stenosis
- Vibration-Based Tools Aim to Improve Newborn Screening for Heart Defects
- Dried Platelet Biologic Reduces Hemorrhage After Traumatic Brain Injury
- Minimally Invasive Probe Measures Key Metabolic Markers Simultaneously
- AI Expands Across Heart Failure Care Continuum to Improve Management
- Wearable Cardiac Monitor with Cellular Transmission Enhances Remote Arrhythmia Detection
- Microneedle Sensor Enables Continuous Monitoring of Drug Clearance
- 3D Brain Imaging Marker Predicts Surgical Outcomes in Dementia-Causing Hydrocephalus
- Printed Artificial Neurons Stimulate Natural Brain Circuits
Channels
Artificial Intelligence
view channel
AI Model Uses Eye Imaging to Identify Risk of Major Systemic Diseases
Early detection of systemic disease risk remains a persistent challenge in population health screening. Cardiometabolic conditions such as diabetes, heart disease, and stroke often progress without symptoms... Read more
AI Platform Interprets Real-Time Wearable Data for Parkinson’s Management
Parkinson’s disease presents fluctuating motor and non-motor symptoms that complicate day-to-day self-management and clinical decision-making. Care teams require timely, longitudinal insight into medication... Read moreSurgical Techniques
view channel
New AI Tool Predicts Complications Before Lung Cancer Surgery
Lung cancer remains a leading cause of cancer mortality, and many surgical candidates present with complex comorbidities. Postoperative complications are common, making accurate and individualized risk... Read more
First Automated Insulin Delivery System Cleared for Type 1 Diabetes in Pregnancy
Managing glycemia during pregnancy complicated by type 1 diabetes requires tight targets and sustained time in a pregnancy-specific glucose range. Clinicians and patients often rely on automated insulin... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
AI System Detects and Quantifies Chronic Subdural Hematoma
Viz.ai (San Francisco, CA, USA) announced a strategic commercialization collaboration with Johnson & Johnson (New Brunswick, NJ, USA) to expand access in the United States to the Viz Subdural solution... Read more
Continuous Monitoring Platform Detects Infection Risk Across Care Transitions
Patients leaving skilled nursing facilities often lose continuous physiologic monitoring, increasing the risk of undetected infection and delayed intervention. Nursing home residents are seven times more... Read more
Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings
Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read morePoint of Care
view channelBusiness
view channel
Johnson & Johnson Launches AI-Driven Cardiac Mapping System
Johnson & Johnson has introduced the CARTOSOUND SONATA Module for the CARTO System at the Heart Rhythm Society (HRS) 2026 meeting in Chicago. The module uses artificial intelligence with the CARTO... Read more







